Abstract
The Taenia saginata taeniasis-cysticercosis complex is a cosmopolitan zoonosis of great medical, veterinary and economic importance where humans play an important role as the carrier of adult stage and cattle as carrier of the larval stage of the parasite. Here we reviewed aspects concerning diagnosis, vaccine development, biological control and treatment of the disease.
Keywords: Biological control, Cysticercus bovis, diagnosis, Taenia saginata, treatment, vaccine, taeniasis-cysticercosis complex, Taeniasis, cysticerci, Taenia solium, ELISA, Echinococcus, PCR, restriction fragment length polymorphism, RFLP, DdeI, loop-mediated isothermal amplification, LAMP, T. crassiceps, Sarcocystis, Actinobacillus, Taenia hydatigena, Taenia taeniaeformis, oncospheres, T. pisiformis, Confocal fluorescence microscopy, Pochonia chlamydosporia, Duddingtonia flagrans, Nematophagous fungi, Monacrosporium, Duddingtonia, Nitazoxanide, Cryptosporidium parvum, Giardia lamblia, Hymenolepis nana, Trichuris trichiura, Ascaris lumbricoides, Fasciola hepatica, Entamoeba histolytica, Taenia solium/saginata
Infectious Disorders - Drug Targets
Title: A Glance at Taenia Saginata Infection, Diagnosis, Vaccine, Biological Control and Treatment
Volume: 10 Issue: 5
Author(s): Claudio V. Silva and Julia M. Costa-Cruz
Affiliation:
Keywords: Biological control, Cysticercus bovis, diagnosis, Taenia saginata, treatment, vaccine, taeniasis-cysticercosis complex, Taeniasis, cysticerci, Taenia solium, ELISA, Echinococcus, PCR, restriction fragment length polymorphism, RFLP, DdeI, loop-mediated isothermal amplification, LAMP, T. crassiceps, Sarcocystis, Actinobacillus, Taenia hydatigena, Taenia taeniaeformis, oncospheres, T. pisiformis, Confocal fluorescence microscopy, Pochonia chlamydosporia, Duddingtonia flagrans, Nematophagous fungi, Monacrosporium, Duddingtonia, Nitazoxanide, Cryptosporidium parvum, Giardia lamblia, Hymenolepis nana, Trichuris trichiura, Ascaris lumbricoides, Fasciola hepatica, Entamoeba histolytica, Taenia solium/saginata
Abstract: The Taenia saginata taeniasis-cysticercosis complex is a cosmopolitan zoonosis of great medical, veterinary and economic importance where humans play an important role as the carrier of adult stage and cattle as carrier of the larval stage of the parasite. Here we reviewed aspects concerning diagnosis, vaccine development, biological control and treatment of the disease.
Export Options
About this article
Cite this article as:
V. Silva Claudio and M. Costa-Cruz Julia, A Glance at Taenia Saginata Infection, Diagnosis, Vaccine, Biological Control and Treatment, Infectious Disorders - Drug Targets 2010; 10 (5) . https://dx.doi.org/10.2174/187152610793180894
DOI https://dx.doi.org/10.2174/187152610793180894 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Fluid-Phase Pinocytosis of LDL by Macrophages: A Novel Target to Reduce Macrophage Cholesterol Accumulation in Atherosclerotic Lesions
Current Pharmaceutical Design Specific Hemosiderin Deposition in Spleen Induced by a Low Dose of Cisplatin: Altered Iron Metabolism and Its Implication as an Acute Hemosiderin Formation Model
Current Drug Metabolism Nanotechnology and Atherosclerosis Imaging: Emerging Diagnostic and Therapeutic Applications
Recent Patents on Cardiovascular Drug Discovery Role of PPAR-γ Agonist Thiazolidinediones in Treatment of Pre-Diabetic and Diabetic Individuals: A Cardiovascular Perspective
Current Drug Targets - Cardiovascular & Hematological Disorders Drug Therapy for Abdominal Aortic Aneurysms Utilizing Omega-3 Unsaturated Fatty Acids and Their Derivatives
Current Drug Targets The Association Between HIV/AIDS During Pregnancy and Fetal Growth Parameters in Florida: A Population Based Study
Current HIV Research Role of Inflammatory Cells and Toll-Like Receptors in Atherosclerosis
Current Vascular Pharmacology Infection, its Treatment and the Risk for Stroke
Current Vascular Pharmacology Non-Steroidal Anti-Inflammatory Drugs used as a Treatment Modality in Subarachnoid Hemorrhage
Current Drug Safety Therapeutic Targeting of P-Selectin in Atherosclerosis
Inflammation & Allergy - Drug Targets (Discontinued) Peroxisome Proliferator-Activated Receptor ?? (PPAR??) and Atherosclerosis
Current Drug Targets - Cardiovascular & Hematological Disorders Pharmacological Management Options to Prevent and Reduce Ischemic Hemorrhagic Transformation
Current Drug Targets Abstracts from Speakers
Cardiovascular & Hematological Disorders-Drug Targets Mitochondrial Targeting for Development of Novel Drug Strategies in Brain Injury
Central Nervous System Agents in Medicinal Chemistry Neuroprotective Methodologies of Co-Enzyme Q10 Mediated Brain Hemorrhagic Treatment: Clinical and Pre-Clinical Findings
CNS & Neurological Disorders - Drug Targets Brain Inflammation Following Intracerebral Hemorrhage
Current Neuropharmacology C-Reactive Protein and Hypertension: Is there A Causal Relationship?
Current Pharmaceutical Design Pleiotropic Actions of PPARg Activators Thiazolidinediones in Cardiovascular Diseases
Current Pharmaceutical Design Safety of Intravenous Thrombolysis in Ischemic Stroke Caused by Left Atrial Myxoma
Current Drug Safety Propofol and Systemic Inflammatory Response in Abdominal Aortic Surgery
Letters in Drug Design & Discovery